Author

Yoshihiro Kita

The University of TokyoORCID 0000-0001-7377-5956Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Hideo ShindouiD· 2 shared Keisuke YanagidaiD· 2 shared Takao ShimizuiD· 2 shared Tomomi Hashidate‐YoshidaiD· 2 shared Tomoyuki SuzukiiD· 2 shared Fumie HamanoiD· 1 shared Hiroaki MitsuyaiD· 1 shared Hiroki NakanishiiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Hideo ShindouORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyPLoS ONEPeer-reviewedJul 22, 2026

Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey

Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida…·Hideo Shindou

The paper identifies a molecular signature in early-stage COVID-19 patients that predicts disease exacerbation using multi-omics analysis of plasma samples.

DOI 10.1371/journal.pone.0352423

humanbulk RNA-seq

𝕏 PostBluesky

BiochemistrybioRxivPreprintNov 2, 2025

MBOAT2 limits the amounts of PUFA in phosphatidylcholine of neonatal and dystrophic skeletal muscle and promotes muscle regeneration

William J. Valentine, Suzumi M. Tokuoka, Tomomi Hashidate‐Yoshida…·Takao Shimizu

This study identifies MBOAT2 as a key enzyme that limits PUFA in PC and promotes muscle regeneration in dystrophic and neonatal muscle.

DOI 10.1101/2025.11.02.686003

mousemetabolomics

𝕏 PostBluesky

Molecular BiologyJournal of the American Society of NephrologyPeer-reviewedAug 29, 2025

Calcineurin inhibition deactivates pyruvate dehydrogenase and induces proximal tubule cell metabolic dysfunction, causing profibrotic phenotype

Yasuhiro Oda, Hiroshi Nishi, Fumie Hamano…·Masaomi Nangaku

The paper shows that calcineurin inhibition deactivates pyruvate dehydrogenase, leading to proximal tubule cell metabolic dysfunction and kidney fibrosis.

5 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky